fda compounding semaglutide crackdown news today Compounded GLP-1s: Why doctors worry and the is cracking down September 2, 2025: U.S. compounding

Keep your data

One suggested practice to managing GI AEs is the Three Es method, which comprises 1) education and explanation, 2) escalation to an appropriate dose, and 3) effective management of GI AEs

They compare patients initiating treatment in a given month to those who initiate 12 months later in a one-year follow-up design and 60 months later in a five-year follow-up design, allowing them to control for underlying time trends and baseline health differences

Some key signals stood out: 1 in 5 products failed stricter claim-related standards Vitamin D showed the highest non-compliance rate 18% of products exceeded EFSA Tolerable Upper Intake Levels Nearly 40% of magnesium-containing products exceeded the magnesium UL 14% did not clearly declare the chemical form of the micronutrient For me, the biggest message is simple: In #supplement #science, the label is only the starting point